Flucloxacillin-Sodium

This page contains recent news articles, when available, and an overview of Flucloxacillin-Sodium but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

European nod for Aurobindo's antibiotic drug  -  Oct 7, 2005
AUROBINDO Pharma Ltd (APL) has announced that it received a European certification for its active pharmaceutical ingredient — flucloxacillin sodium. ... Hindu Business Line

WHO expert committee on specifications for pharmaceutical preparations...  -  Aug 1, 2005
9930306 ethisterone 100mg 167017 9930307 ethosuximide 100mg 179088 9930309 flucloxacillin sodium 200mg 195194 9930310 flucytosine 100mg 184121 9930311 ... Free with registration - Technical Report Series - AccessMyLibrary.com

Aurobindo Pharma Ltd seeking buyer for minority stake - Deal Snapshot...  -  May 13, 2005
Espicom Business Intelligence ## UK Aurobindo gains UK sertraline approval Aurobindo Pharma has announced the UK MHRA…flucloxacillin sodium Certificate of ... Pay-Per-View - deals - Alacra Store





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy